Biosergen AB (8N10) Stock Price & News

All values in SEK	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	131.00K	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	12.73M	5.88M	5.33M	5.33M
Operating expense	12.19M	9.67M	5.24M	5.24M
Total operating expenses	12.19M	9.67M	5.24M	5.24M
Operating income	-12.19M	-9.67M	-5.24M	-5.24M
Other non operating income	-	-	-	-
EBT including unusual items	-12.17M	-9.66M	-5.24M	-5.24M
EBT excluding unusual items	-12.17M	-9.66M	-5.24M	-5.24M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-537.00K	3.79M	-95.50K	-95.50K
Net income	-12.17M	-9.66M	-5.24M	-5.24M
Net profit margin	-	-	-	-
Earnings per share	-5.00	-	-	-
Interest and investment income	22.00K	18.00K	-	-
Interest expense	-	-4.00K	-7.50K	-7.50K
Net interest expenses	22.00K	14.00K	-7.50K	-7.50K
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-	-	-	-

Finance